Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia with cyclosporin A
Authors:
Abstract
Angioimmunoblastic lymphadenopathy with dysproteinemia (AILD) is a lymphoma-like disease. Although the histologic appearance of this disease is benign, it is clinically malignant, with chemotherapy being ineffective and the prognosis being poor. In this article, the authors report the results of treating two patients with AILD with cyclosporin A. One patient had cervical lymphadenopathy and fever, and AILD was refractory to both chemotherapy and a-interferon. However, treatment with cyclosporin A achieved complete remission. The other patient had generalized lymphadenopathy, and cyclosporin A was used as the treatment of first choice. Complete remission also was achieved in this patient, who still is in remission. These two cases demonstrate that cyclosporin A can be effective for treating AILD.Keywords
This publication has 10 references indexed in Scilit:
- Mechanism of action and rationale for cyclosporin A in psoriasisBritish Journal of Dermatology, 1990
- Polyclonal rearrangements of the T‐cell receptor β‐chain in fatal angioimmunoblastic lymphadenopathyBritish Journal of Haematology, 1989
- Danazol in treatment of angio-immunoblastic lymphadenopathyCancer, 1989
- Alpha-Interferon in Angioimmunoblastic LymphadenopathyAnnals of Internal Medicine, 1988
- Angioimmunoblastic Lymphadenopathy with DysproteinemiaAnnals of Internal Medicine, 1988
- ALPHA‐INTERFERON THERAPY IN REFRACTORY ANGIOIMMUNO‐BLASTIC LYMPHADENOPATHYEuropean Journal of Haematology, 1987
- Studies of the pathogenesis of angioimmunoblastic lymphadenopathy.Journal of Clinical Investigation, 1985
- Angio-immunoblastic lymphadenopathyThe American Journal of Medicine, 1975
- Immunoblastic LymphadenopathyNew England Journal of Medicine, 1975
- ANGIO-IMMUNOBLASTIC LYMPHADENOPATHY WITH DYSPROTEINÆMIAThe Lancet, 1974